Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders

Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders

US Patent 7982005 · Granted Jul 19, 2011

Estimated economic value: $19,589,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cyclic peptide antiviral agents and methods using same2025
Cyclic peptides and methods using same2019
Compositions for promoting HIV-1 virolysis and methods using same2016
Compositions for inhibiting virus entry and promoting virolysis, and methods the2015
Active cores of peptide triazole HIV-1 entry inhibitors2015
Active cores of peptide triazole HIV-1 entry inhibitors2013
Dual inhibitors of HIV-1 gp-120 interactions2012
CVN-12p1: a recombinant allosteric lectin antagonist of HIV-1 envelope gp120 int2012
Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders2010
Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders2010
Dual inhibitors of HIV-1 GP-120 interactions2010
Dual inhibitors of HIV-1 gp-120 interactions2009